{"id":"https://openalex.org/W2806629158","doi":"https://doi.org/10.1001/jamaoncol.2018.1380","title":"Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2\u2013Positive Breast Cancer: The SOLD Randomized Clinical Trial","display_name":"Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2\u2013Positive Breast Cancer: The SOLD Randomized Clinical Trial","alternate_titles":[],"publication_year":2018,"publication_date":"2018-05-31","ids":{"openalex":"https://openalex.org/W2806629158","doi":"https://doi.org/10.1001/jamaoncol.2018.1380","mag":"2806629158","pmid":"https://pubmed.ncbi.nlm.nih.gov/29852043","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6143012"},"language":"en","primary_location":{"id":"doi:10.1001/jamaoncol.2018.1380","doi":"https://doi.org/10.1001/jamaoncol.2018.1380","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2018.1380","pdf_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2682589/jamaoncology_joensuu_2018_oi_180027.pdf","source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2806629158"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2682589/jamaoncology_joensuu_2018_oi_180027.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090618504","display_name":"Heikki Joensuu","orcid":"https://orcid.org/0000-0003-0281-2507","observed_orcids":["https://orcid.org/0000-0003-0281-2507"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Heikki Joensuu","raw_affiliation_strings":["Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077303065","display_name":"Judith Fraser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Judith Fraser","raw_affiliation_strings":["Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom","institution_ids":["https://openalex.org/I2800373718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052697647","display_name":"Hans P. M. W. Wildiers","orcid":"https://orcid.org/0000-0001-8990-7837","observed_orcids":["https://orcid.org/0000-0001-8990-7837"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hans Wildiers","raw_affiliation_strings":["University Hospitals Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060101257","display_name":"Riikka Huovinen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801970007","display_name":"Turku University Hospital","ror":"https://ror.org/05dbzj528","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2801970007","https://openalex.org/I4210127022"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Riikka Huovinen","raw_affiliation_strings":["Department of Oncology, Turku University Central Hospital, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Turku University Central Hospital, Turku, Finland","institution_ids":["https://openalex.org/I2801970007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029186353","display_name":"P\u00e4ivi Auvinen","orcid":"https://orcid.org/0000-0002-2392-9395","observed_orcids":["https://orcid.org/0000-0002-2392-9395"]},"institutions":[{"id":"https://openalex.org/I4210092991","display_name":"Kuopio University Hospital","ror":"https://ror.org/00fqdfs68","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210092991","https://openalex.org/I4405278559"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P\u00e4ivi Auvinen","raw_affiliation_strings":["Department of Oncology, Kuopio University Hospital, Kuopio, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Kuopio University Hospital, Kuopio, Finland","institution_ids":["https://openalex.org/I4210092991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064615239","display_name":"Meri Utriainen","orcid":"https://orcid.org/0000-0002-6727-2268","observed_orcids":["https://orcid.org/0000-0002-6727-2268"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Meri Utriainen","raw_affiliation_strings":["Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034398436","display_name":"Paul Nyandoto","orcid":"https://orcid.org/0000-0002-3065-0763","observed_orcids":["https://orcid.org/0000-0002-3065-0763"]},"institutions":[{"id":"https://openalex.org/I4210131690","display_name":"P\u00e4ij\u00e4t-H\u00e4meen Keskussairaala","ror":"https://ror.org/02v92t976","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210131690"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Nyandoto","raw_affiliation_strings":["P\u00e4ij\u00e4t-H\u00e4me Central Hospital, Lahti, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"P\u00e4ij\u00e4t-H\u00e4me Central Hospital, Lahti, Finland","institution_ids":["https://openalex.org/I4210131690"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110538601","display_name":"Kenneth Villman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129463","display_name":"\u00d6rebro University Hospital","ror":"https://ror.org/02m62qy71","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210129463"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kenneth K. Villman","raw_affiliation_strings":["\u00d6rebro University Hospital, \u00d6rebro, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u00d6rebro University Hospital, \u00d6rebro, Sweden","institution_ids":["https://openalex.org/I4210129463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015216467","display_name":"P\u00e4ivi Halonen","orcid":"https://orcid.org/0000-0002-9760-0840","observed_orcids":["https://orcid.org/0000-0002-9760-0840"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P\u00e4ivi Halonen","raw_affiliation_strings":["Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085393676","display_name":"Helena Granstam Bj\u00f6rneklett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107839","display_name":"V\u00e4ster\u00e5s Municipality","ror":"https://ror.org/01rrc6194","country_code":"SE","type":"government","lineage":["https://openalex.org/I4210107839"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Helena Granstam-Bj\u00f6rneklett","raw_affiliation_strings":["V\u00e4ster\u00e5s Central Hospital, V\u00e4ster\u00e5s, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"V\u00e4ster\u00e5s Central Hospital, V\u00e4ster\u00e5s, Sweden","institution_ids":["https://openalex.org/I4210107839"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012167716","display_name":"Lotta Lundgren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137844","display_name":"Sk\u00e5ne University Hospital","ror":"https://ror.org/02z31g829","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210137844"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lotta Lundgren","raw_affiliation_strings":["Sk\u00e5ne University Hospital, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sk\u00e5ne University Hospital, Lund, Sweden","institution_ids":["https://openalex.org/I4210137844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077452497","display_name":"Liisa Sailas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089552","display_name":"North Karelia Central Hospital","ror":"https://ror.org/007vcvm35","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210089552"]},{"id":"https://openalex.org/I4210103236","display_name":"Vaasa Central Hospital","ror":"https://ror.org/019xaj585","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210103236"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Liisa Sailas","raw_affiliation_strings":["North Carelia Central Hospital, Joensuu, Finland","Vaasa Central Hospital, Vaasa, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"North Carelia Central Hospital, Joensuu, Finland","institution_ids":["https://openalex.org/I4210089552"]},{"raw_affiliation_string":"Vaasa Central Hospital, Vaasa, Finland","institution_ids":["https://openalex.org/I4210103236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006535775","display_name":"Taina M. Turpeenniemi-Hujanen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799272722","display_name":"Oulu University Hospital","ror":"https://ror.org/045ney286","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2799272722"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Taina Turpeenniemi-Hujanen","raw_affiliation_strings":["Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland","institution_ids":["https://openalex.org/I2799272722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033221430","display_name":"Minna Tanner","orcid":"https://orcid.org/0000-0002-3012-8641","observed_orcids":["https://orcid.org/0000-0002-3012-8641"]},"institutions":[{"id":"https://openalex.org/I4210126318","display_name":"Tampere University Hospital","ror":"https://ror.org/02hvt5f17","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210126318"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Minna Tanner","raw_affiliation_strings":["Department of Oncology, Tampere University Hospital, Tampere, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Tampere University Hospital, Tampere, Finland","institution_ids":["https://openalex.org/I4210126318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004159775","display_name":"Jeffrey Yachnin","orcid":"https://orcid.org/0009-0009-3656-9657","observed_orcids":["https://orcid.org/0009-0009-3656-9657"]},"institutions":[{"id":"https://openalex.org/I3171673259","display_name":"Eskilstuna Municipality","ror":"https://ror.org/0434pxk87","country_code":"SE","type":"government","lineage":["https://openalex.org/I3171673259"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey Yachnin","raw_affiliation_strings":["Eskilstuna Hospital, Eskilstuna, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eskilstuna Hospital, Eskilstuna, Sweden","institution_ids":["https://openalex.org/I3171673259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112274037","display_name":"Diana Ritchie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Diana Ritchie","raw_affiliation_strings":["Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom","institution_ids":["https://openalex.org/I2800373718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109401991","display_name":"Oskar Johansson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106610","display_name":"National University Hospital of Iceland","ror":"https://ror.org/011k7k191","country_code":"IS","type":"healthcare","lineage":["https://openalex.org/I4210106610"]}],"countries":["IS"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Oskar Johansson","raw_affiliation_strings":["Landspitali University Hospital, Reykjavik, Iceland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Landspitali University Hospital, Reykjavik, Iceland","institution_ids":["https://openalex.org/I4210106610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081430827","display_name":"Teppo Huttunen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Teppo Huttunen","raw_affiliation_strings":["4Pharma, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Pharma, Turku, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007579054","display_name":"Patrick Neven","orcid":"https://orcid.org/0000-0002-1434-9460","observed_orcids":["https://orcid.org/0000-0002-1434-9460"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patrick Neven","raw_affiliation_strings":["University Hospitals Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111962084","display_name":"Peter A. Canney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Canney","raw_affiliation_strings":["Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom","institution_ids":["https://openalex.org/I2800373718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110146440","display_name":"Vernon J. Harvey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801418622","display_name":"Auckland City Hospital","ror":"https://ror.org/05e8jge82","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I2801418622","https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vernon J. Harvey","raw_affiliation_strings":["Auckland City Hospital, Auckland, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auckland City Hospital, Auckland, New Zealand","institution_ids":["https://openalex.org/I2801418622"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108397793","display_name":"Pirkko\u2010Liisa Kellokumpu\u2010Lehtinen","orcid":"https://orcid.org/0000-0002-5557-0911","observed_orcids":["https://orcid.org/0000-0002-5557-0911"]},"institutions":[{"id":"https://openalex.org/I4210126318","display_name":"Tampere University Hospital","ror":"https://ror.org/02hvt5f17","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210126318"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pirkko\u2013Liisa Kellokumpu-Lehtinen","raw_affiliation_strings":["Department of Oncology, Tampere University Hospital, Tampere, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Tampere University Hospital, Tampere, Finland","institution_ids":["https://openalex.org/I4210126318"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065433718","display_name":"Henrik Lindman","orcid":"https://orcid.org/0000-0002-5871-268X","observed_orcids":["https://orcid.org/0000-0002-5871-268X"]},"institutions":[{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Henrik Lindman","raw_affiliation_strings":["Uppsala University Hospital, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uppsala University Hospital, Uppsala, Sweden","institution_ids":["https://openalex.org/I1342360035"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":18,"corresponding_author_ids":["https://openalex.org/A5090618504"],"corresponding_institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"],"apc_list":null,"apc_paid":null,"fwci":10.5748,"has_fulltext":true,"cited_by_count":174,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.99099155,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"4","issue":"9","first_page":"1199","last_page":"1199"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.8989999890327454},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.8790000081062317},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9010000228881836},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.8019999861717224},{"id":"https://openalex.org/keywords/fec-chemotherapy","display_name":"FEC chemotherapy","score":0.6729999780654907},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.8220000267028809},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7039999961853027},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.8069999814033508},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.31200000643730164},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.47600001096725464},{"id":"https://openalex.org/keywords/trastuzumab-emtansine","display_name":"trastuzumab emtansine","score":0.5600000023841858},{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9124724268913269},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.9087125062942505},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.8637358546257019},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.6888409852981567},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6512666940689087},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6249538064002991},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5865422487258911},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.5031320452690125},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.4974110424518585},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4762582778930664},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.4198121726512909},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35933011770248413}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1001/jamaoncol.2018.1380","doi":"https://doi.org/10.1001/jamaoncol.2018.1380","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2018.1380","pdf_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2682589/jamaoncology_joensuu_2018_oi_180027.pdf","source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/626932","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/626932","pdf_url":"https://lirias.kuleuven.be/retrieve/5877ff5e-5383-407e-8ee3-9c4ec74d5a7b","source":{"id":"https://openalex.org/S4306401954","display_name":"Lirias (KU Leuven)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology, vol. 4 (9), (1199-1206)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:europepmc.org:5097580","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6143012","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6143012","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6143012/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncol","raw_type":"Text"},{"id":"pmid:29852043","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29852043","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA oncology","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:helda.helsinki.fi:10138/248394","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10138/248394","pdf_url":null,"source":{"id":"https://openalex.org/S4406922691","display_name":"Helda - University of Helsinki Institutional Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:www.hirsla.lsh.is:2336/620723","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2336/620723","pdf_url":null,"source":{"id":"https://openalex.org/S4306401083","display_name":"Hirsla (Landsp\u00edtali University Hospital)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210106610","host_organization_name":"National University Hospital of Iceland","host_organization_lineage":["https://openalex.org/I4210106610"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JAMA oncology","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1001/jamaoncol.2018.1380","doi":"https://doi.org/10.1001/jamaoncol.2018.1380","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2018.1380","pdf_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2682589/jamaoncology_joensuu_2018_oi_180027.pdf","source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320322282","display_name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","ror":"https://ror.org/03vxy9y38"},{"id":"https://openalex.org/F4320323824","display_name":"Sy\u00f6p\u00e4j\u00e4rjest\u00f6t","ror":"https://ror.org/05pgg4z49"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2806629158.pdf","grobid_xml":"https://content.openalex.org/works/W2806629158.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W222594567","https://openalex.org/W1925211454","https://openalex.org/W1926958054","https://openalex.org/W1996778928","https://openalex.org/W1996896645","https://openalex.org/W1999130958","https://openalex.org/W2034414538","https://openalex.org/W2039407184","https://openalex.org/W2040935952","https://openalex.org/W2089071484","https://openalex.org/W2090295140","https://openalex.org/W2096884232","https://openalex.org/W2098775844","https://openalex.org/W2099067294","https://openalex.org/W2108182027","https://openalex.org/W2114228256","https://openalex.org/W2130034035","https://openalex.org/W2144124503","https://openalex.org/W2144683140","https://openalex.org/W2145774014","https://openalex.org/W2146384083","https://openalex.org/W2149908785","https://openalex.org/W2171277704","https://openalex.org/W2173858545","https://openalex.org/W2187103971","https://openalex.org/W2209859982","https://openalex.org/W2328600489","https://openalex.org/W2588881638","https://openalex.org/W2624443052","https://openalex.org/W2624590002","https://openalex.org/W2734795522","https://openalex.org/W4249999102"],"related_works":["https://openalex.org/W2090752983","https://openalex.org/W1601636075","https://openalex.org/W4401882758","https://openalex.org/W2790779590","https://openalex.org/W2907877190","https://openalex.org/W3081807968","https://openalex.org/W2624443052","https://openalex.org/W2936228289","https://openalex.org/W2171277704","https://openalex.org/W2591307428"],"abstract_inverted_index":{"Importance:":[0],"Trastuzumab":[1],"plus":[2,102,184],"chemotherapy":[3,41,56,62],"is":[4,29],"the":[5,23,32,40,47,87,122,141,148,230,253,280,289,292,299,308,316,323,344,372],"standard":[6,24],"adjuvant":[7,52],"treatment":[8,28,255],"for":[9,104,186,260],"patients":[10,157,176,287,321,342],"with":[11,60,79,160,327,335,364,378],"human":[12],"epidermal":[13],"growth":[14],"factor":[15],"receptor":[16],"2":[17,88],"(HER2)-positive":[18],"early":[19],"breast":[20,81],"cancer.":[21,82],"While":[22],"duration":[25],"of":[26,36,51,91,94,111,133,165,193,252,352,360],"trastuzumab":[27,37,53,103,118,128,185,203,353,361,379],"12":[30],"months,":[31],"benefits":[33],"and":[34,49,66,70,114,147,196,209,226,272,284,291,319,332,348],"harms":[35],"continued":[38,54,202],"beyond":[39,55],"are":[42],"unclear.":[43],"Objective:":[44],"To":[45],"evaluate":[46],"efficacy":[48],"safety":[50,368],"in":[57,86,121,198,288,307,322,343,371],"women":[58,78,232],"treated":[59,326,334],"up-front":[61],"containing":[63],"a":[64,144,161],"taxane":[65],"trastuzumab.":[67],"Design,":[68],"Setting,":[69],"Participants:":[71],"Open-label,":[72],"randomized":[73],"(1:1)":[74],"clinical":[75],"trial":[76],"including":[77],"HER2-positive":[80],"Chemotherapy":[83],"was":[84,119,138,155,214,236,246,304,313,354,369],"identical":[85],"groups,":[89,294],"consisting":[90],"3":[92,109,191],"cycles":[93,110,192],"3-weekly":[95],"docetaxel":[96,317,376],"(either":[97],"80":[98,328],"or":[99],"100":[100,336],"mg/m2)":[101],"9":[105,187],"weeks,":[106,188],"followed":[107,189],"by":[108,190],"fluorouracil,":[112,194],"epirubicin,":[113,195],"cyclophosphamide.":[115],"Thereafter,":[116],"no":[117],"administered":[120],"9-week":[123,254,293,309,324,373],"group,":[124],"whereas":[125],"controls":[126],"received":[127],"to":[129,171,204,357],"complete":[130],"1":[131,205,358],"year":[132,359],"administration.":[134],"Disease-free":[135],"survival":[136,271,274],"(DFS)":[137],"compared":[139],"between":[140,279,315],"groups":[142],"using":[143],"Cox":[145],"model":[146],"noninferiority":[149,163],"approach.":[150],"The":[151,211,243,375],"estimated":[152],"sample":[153],"size":[154],"2168":[156],"(1-sided":[158],"testing,":[159],"relative":[162],"margin":[164],"1.3).":[166],"From":[167],"January":[168],"3,":[169],"2008,":[170],"December":[172],"16,":[173],"2014,":[174],"2176":[175],"were":[177],"accrued":[178],"from":[179],"7":[180],"countries.":[181],"Intervention:":[182],"Docetaxel":[183],"cyclophosphamide":[197],"both":[199],"groups.":[200,281],"Controls":[201],"year.":[206],"Main":[207],"Outcomes":[208],"Measures:":[210],"primary":[212],"objective":[213],"DFS;":[215,320],"secondary":[216],"objectives":[217],"included":[218],"distant":[219],"disease-free":[220,270],"survival,":[221,223],"overall":[222,273],"cardiac":[224,297],"DFS,":[225],"safety.":[227],"Results:":[228],"In":[229],"2174":[231],"analyzed,":[233],"median":[234,244],"age":[235],"56":[237],"(interquartile":[238],"range":[239],"[IQR],":[240],"48-64)":[241],"years.":[242,250],"follow-up":[245],"5.2":[247],"(IQR,":[248],"3.8-6.7)":[249],"Noninferiority":[251],"could":[256],"not":[257,276,355],"be":[258],"demonstrated":[259],"DFS":[261,340],"(hazard":[262],"ratio,":[263],"1.39;":[264],"2-sided":[265],"90%":[266],"CI,":[267],"1.12-1.72).":[268],"Distant":[269],"did":[275],"differ":[277],"substantially":[278],"Thirty-six":[282],"(3%)":[283],"21":[285],"(2%)":[286],"1-year":[290,345],"respectively,":[295],"had":[296,330,338],"failure;":[298],"left":[300],"ventricle":[301],"ejection":[302],"fraction":[303],"better":[305,370],"maintained":[306],"group.":[310,346,374],"An":[311],"interaction":[312],"detected":[314],"dose":[318],"group":[325],"mg/m2":[329,337],"inferior":[331],"those":[333],"similar":[339,365],"as":[341],"Conclusions":[347],"Relevance:":[349],"Nine":[350],"weeks":[351],"noninferior":[356],"when":[362],"given":[363],"chemotherapy.":[366],"Cardiac":[367],"dosing":[377],"requires":[380],"further":[381],"study.":[382],"Trial":[383],"Registration:":[384],"ClinicalTrials.gov":[385],"Identifier:":[386],"NCT00593697.":[387]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2806629158","counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":18},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":19},{"year":2021,"cited_by_count":25},{"year":2020,"cited_by_count":37},{"year":2019,"cited_by_count":34},{"year":2018,"cited_by_count":14}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-06-13T00:00:00"}
